Literature DB >> 32660940

SARS-CoV-2-related chilblains.

Malika A Ladha1, Elaine C Dupuis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32660940      PMCID： PMC7828869          DOI： 10.1503/cmaj.201348

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011.

Authors:  Jonathan A Cappel; David A Wetter
Journal:  Mayo Clin Proc       Date:  2014-02       Impact factor: 7.616

2.  Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.

Authors:  Esther E Freeman; Devon E McMahon; Jules B Lipoff; Misha Rosenbach; Carrie Kovarik; Junko Takeshita; Lars E French; Bruce H Thiers; George J Hruza; Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2020-05-30       Impact factor: 11.527

3.  Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.

Authors:  C Galván Casas; A Català; G Carretero Hernández; P Rodríguez-Jiménez; D Fernández-Nieto; A Rodríguez-Villa Lario; I Navarro Fernández; R Ruiz-Villaverde; D Falkenhain-López; M Llamas Velasco; J García-Gavín; O Baniandrés; C González-Cruz; V Morillas-Lahuerta; X Cubiró; I Figueras Nart; G Selda-Enriquez; J Romaní; X Fustà-Novell; A Melian-Olivera; M Roncero Riesco; P Burgos-Blasco; J Sola Ortigosa; M Feito Rodriguez; I García-Doval
Journal:  Br J Dermatol       Date:  2020-06-10       Impact factor: 11.113

4.  Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Authors:  V Piccolo; I Neri; C Filippeschi; T Oranges; G Argenziano; V C Battarra; S Berti; F Manunza; A B Fortina; V Di Lernia; V Boccaletti; G De Bernardis; B Brunetti; C Mazzatenta; A Bassi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166
  4 in total
  6 in total

1.  Case did not consider all potential causes of chilblains.

Authors:  Catharine L Dewar
Journal:  CMAJ       Date:  2020-09-08       Impact factor: 8.262

2.  Beau lines associated with COVID-19.

Authors:  Saud Alobaida; Joseph M Lam
Journal:  CMAJ       Date:  2020-09-08       Impact factor: 8.262

3.  The authors respond to: "Case did not consider all potential causes of chilblains".

Authors:  Malika A Ladha; Elaine C Dupuis
Journal:  CMAJ       Date:  2020-09-08       Impact factor: 8.262

Review 4.  Chilblains-Like Lesions in Pediatric Patients: A Review of Their Epidemiology, Etiology, Outcomes, and Treatment.

Authors:  Jessica Fennell; Karen Onel
Journal:  Front Pediatr       Date:  2022-06-23       Impact factor: 3.569

Review 5.  "COVID toes": A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings.

Authors:  Kelvin Oliveira Rocha; Virgínia Vinha Zanuncio; Brunnella Alcântara Chagas de Freitas; Luciana Moreira Lima
Journal:  Pediatr Dermatol       Date:  2021-09-13       Impact factor: 1.588

Review 6.  Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.

Authors:  Marcello Lanari; Iria Neri; Arianna Dondi; Giacomo Sperti; Davide Gori; Federica Guaraldi; Marco Montalti; Lorenza Parini; Bianca Maria Piraccini
Journal:  Eur J Pediatr       Date:  2022-08-10       Impact factor: 3.860
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.